Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia

2000 ◽  
Vol 150 (3) ◽  
pp. 237-243 ◽  
Author(s):  
S.J. Cooper ◽  
A. Butler ◽  
J. Tweed ◽  
C. Welch ◽  
J. Raniwalla
Keyword(s):  
Chronic Schizophrenia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Prevention Of Recurrence

Nilvadipine Is Effective for Chronic Schizophrenia in a Double-Blind Placebo-Controlled Study

1996 ◽  
Vol 16 (6) ◽  
pp. 437-439 ◽  
Author(s):  
Kazuo Yamada ◽  
Shigenobu Kanba ◽  
Iyoko Ashikari ◽  
Kimio Ohnishi ◽  
Gohei Yagi ◽  
...  
Keyword(s):  
Chronic Schizophrenia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

Treatment of chronic schizophrenia with cyproheptadine: A double-blind placebo-controlled study

1991 ◽  
Vol 30 (5) ◽  
pp. 523-525 ◽  
Author(s):  
Henry Silver ◽  
Michael Blacker ◽  
Malcolm P.I. Weller ◽  
Bernard Lerer
Keyword(s):  
Chronic Schizophrenia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study

1996 ◽  
Vol 94 (3) ◽  
pp. 175-180 ◽  
Author(s):  
R. K. R. Salokangas ◽  
S. Saarijärvi ◽  
T. Taiminen ◽  
H. Kallioniemi ◽  
H. Lehto ◽  
...  
Keyword(s):  
Chronic Schizophrenia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

Oxypertine in Tardive Dyskinesia: An 8-week Controlled Study

1984 ◽  
Vol 144 (1) ◽  
pp. 48-52 ◽  
Author(s):  
S. D. Soni ◽  
H. L. Freeman ◽  
E. M. Hussein
Keyword(s):  
Tardive Dyskinesia ◽  
Controlled Trial ◽  
Chronic Schizophrenia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

SummaryIn a double-blind placebo controlled trial of oxypertine in the treatment of tardive dyskinesia, 33 patients with chronic schizophrenia received either oxypertine or placebo. At the end of eight weeks, the results showed that oxypertine was superior to placebo at a statistically significant level.

Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study

2017 ◽  
Vol 32 (4) ◽  
pp. e2583 ◽  
Author(s):  
Farzin Rezaei ◽  
Bita Mesgarpour ◽  
Alireza Jeddian ◽  
Atefeh Zeionoddini ◽  
Payam Mohammadinejad ◽  
...  
Keyword(s):  
Adjunctive Therapy ◽  
Negative Symptoms ◽  
Chronic Schizophrenia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document